Fatigue from beta blockers

Searched over 200M research papers

Research Analysis by Consensus

Beta · 20 papers

Consensus Meter

Yes

Possibly

Fatigue from Beta Blockers: An Overview

Introduction to Beta Blockers and Their Uses

Beta blockers, first reported for their hypotensive effects in 1964, are widely used to treat various cardiovascular conditions such as hypertension, angina pectoris, cardiac arrhythmias, and for secondary prevention of myocardial infarction. Despite their benefits, beta blockers are associated with several side effects, including fatigue, which can significantly impact patients' quality of life .

Incidence and Types of Fatigue

General and Localized Fatigue

Fatigue associated with beta blockers can manifest as general or localized fatigue. General fatigue is characterized by an overall sense of tiredness, both physical and mental, that persists throughout the day. Localized fatigue typically affects the limbs, particularly the legs. Studies have shown varying incidences of fatigue among patients, with some reports indicating rates as high as 30%.

Comparative Studies on Different Beta Blockers

Comparative studies have shown that the incidence of fatigue can vary between different beta blockers. For instance, propranolol and atenolol have been associated with similar rates of fatigue, while newer beta blockers like celiprolol may cause less fatigue and dyspnea during exercise .

Mechanisms Contributing to Fatigue

Cardiovascular and Metabolic Effects

Beta blockers can impair exercise performance by affecting cardiovascular and metabolic functions. They reduce heart rate response to physical exertion, which can lead to increased fatigue during activities. Additionally, beta blockers inhibit Na(+)-K+ ATPase pumps, which control ion movement between muscle and plasma, potentially contributing to muscle fatigue.

Central Nervous System Effects

The degree of lipophilicity of beta blockers can influence their ability to cross the blood-brain barrier and cause central nervous system (CNS) side effects such as tiredness and fatigue. For example, atenolol, a hydrophilic beta blocker, has been associated with CNS side effects, while other beta blockers with different lipophilicity profiles may have varying impacts.

Quantitative Analysis of Fatigue

Meta-Analyses and Large-Scale Studies

Meta-analyses and large-scale studies have quantified the risk of fatigue associated with beta blocker therapy. One study involving over 35,000 subjects found that beta blockers were associated with a small but significant increase in the risk of reported fatigue, equivalent to one additional report of fatigue for every 57 patients treated per year. Another study using visual analogue scales (VAS) confirmed that patients on beta blockers experienced a greater incidence of tiredness in the legs compared to those not on these medications.

Impact on Work Capacity

Beta blockers can also affect work capacity, particularly in physically demanding jobs. Hypertensive males treated with beta blockers reported higher fatigue scores and reduced heart rate response to physical work compared to untreated hypertensives and normotensives.

Management and Tolerability

Switching Beta Blockers

In cases where fatigue becomes intolerable, switching to a different beta blocker may be beneficial. Studies have shown that a significant proportion of patients who discontinued one beta blocker due to fatigue were able to tolerate another beta blocker. This suggests that individual responses to different beta blockers can vary, and personalized treatment adjustments may help mitigate fatigue.

Conclusion

Fatigue is a common side effect of beta blocker therapy, influenced by various factors including the specific beta blocker used, its lipophilicity, and individual patient characteristics. While the incidence of fatigue can be significant, understanding the mechanisms and managing therapy through personalized adjustments can help improve patient outcomes. The benefits of beta blockers in treating cardiovascular conditions often outweigh the risks of fatigue, but careful monitoring and management are essential to optimize therapy.